Ignite Creation Date:
2024-07-17 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466798
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-13
Brief Title:
Fourth Ventricular Administration of Immune Checkpoint Inhibitor Nivolumab and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma Ependymoma and Other CNS Malignancies
Sponsor:
David Ilan Sandberg
Organization:
The University of Texas Health Science Center Houston
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Ependymoma |
| Recurrent Medulloblastoma |
| CNS Malignancies |
Keywords: